Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins (Q44174112)

30 November 2017

Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins (English)

1 reference

30 November 2017

0 references

1

1 reference

30 November 2017

4

1 reference

30 November 2017

Zhi J Zhang

2

1 reference

PubMed ID

12372661

30 November 2017

Iain Patten

series ordinal

3

1 reference

PubMed ID

12372661

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

Biological Psychiatry

1 reference

30 November 2017

52

1 reference

30 November 2017

7

1 reference

30 November 2017

708-715

1 reference

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Postnatal development of parvalbumin immunoreactivity in axon terminals of basket and chandelier neurons in monkey neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Two-dimensional versus three-dimensional cell counting: a practical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Calbindin D-28k and parvalbumin in the rat nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Parvalbumin immunoreactivity reveals layer IV of monkey cerebral cortex as a mosaic of microzones of thalamic afferent terminations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Heterogeneity of GABAergic cells in cat visual cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Effects of microwave pretreatment on immunocytochemical staining of vibratome sections and tissue blocks of human cerebral cortex stored in formaldehyde fixative for long periods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Immunocytochemical localization of calretinin in the forebrain of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Altered distribution of parvalbumin-immunoreactive local circuit neurons in the anterior cingulate cortex of schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Decrease in GABA immunoreactivity and alteration of GABA metabolism after kindling in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbumin-immunoreactive populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Cytoarchitectonic Definition of Prefrontal Areas in the Normal Human Cortex: I. Remapping of Areas 9 and 46 using Quantitative Criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

The stanley foundation brain collection and neuropathology consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901360-4

10.1016/S0006-3223(02)01360-4

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12372661